1. Impact of 5-HT3 RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting. (August 2011) Authors: Schwartzberg, Lee; Jackson, James; Jain, Gagan; Balu, Sanjeev; Buchner, Deborah Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 11:Number 4(2011) Page Start: 481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of 5-HT3 RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting. (August 2011) Authors: Schwartzberg, Lee; Jackson, James; Jain, Gagan; Balu, Sanjeev; Buchner, Deborah Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 11:Number 4(2011) Page Start: 481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of 5-HT3 RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting. (August 2011) Authors: Schwartzberg, Lee; Jackson, James; Jain, Gagan; Balu, Sanjeev; Buchner, Deborah Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 11:Number 4(2011) Page Start: 481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of 5-HT3 RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting. (August 2011) Authors: Schwartzberg, Lee; Jackson, James; Jain, Gagan; Balu, Sanjeev; Buchner, Deborah Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 11:Number 4(2011) Page Start: 481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The burden of diurnal and nocturnal gastroesophageal reflux disease symptoms. (December 2011) Authors: Wagner, Jan-Samuel; DiBonaventura, Marco daCosta; Balu, Sanjeev; Buchner, Deborah Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 11:Number 6(2011) Page Start: 739 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Willingness to pay to prevent chemotherapy induced nausea and vomiting among patients with breast, lung, or colorectal cancer. (October 2013) Authors: Miller, Paul J. E.; Balu, Sanjeev; Buchner, Deborah; Walker, Mark S.; Stepanski, Edward J.; Schwartzberg, Lee S. Journal: Journal of medical economics Issue: Volume 16:Number 10(2013) Page Start: 1179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗